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Cellular Niches Controlling B Lymphocyte Behavior
within Bone Marrow during Development
stromal cells in bone marrow makes it difficult to identify
the niches for hematopoiesis. Spatial microenvironmen-
tal organization of blood cells and their interaction with
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Mobilization and stromal cell interactions of hemato-
poietic precursors are thought to be controlled by cyto-
kines, particularly, chemokines, structurally relatedSummary
small chemoattractive proteins (Baggiolini et al., 1997).
Among chemokines, CXC chemokine ligand (CXCL)12In bone marrow, hematopoiesis is thought to depend
(stromal cell-derived factor (SDF)-1/pre-B-cell-growth-on special microenvironments known as niches that
stimulating factor (PBSF)) is particularly intriguing be-maintain blood cells. However, the identity of niches
cause it has been shown definitively to be involved inand interaction of blood cells with niches remain
various developmental processes including hematopoi-poorly understood. Here we identify stage-specific
esis (Nagasawa et al., 1996, 1999; Nagasawa, 2000).cellular niches for B lymphopoiesis. The earliest pre-
CXCL12 was first characterized as a pre-B-cell growth-cursors, pre-pro-B cells and end-stage B cells, plasma
stimulating factor (Nagasawa et al., 1994, 1999) andcells require CXC chemokine ligand (CXCL)12. CXCL12-
the primary physiologic receptor for CXCL12 is CXCR4,
expressing cells are a small population of stromal
which also functions as an entry receptor for strains of
cells, scattered throughout bone marrow and located
HIV-1 (Bleul et al., 1996; Feng et al., 1996; Nagasawa et
some distance from the cells expressing interleukin al., 1996; Oberlin et al., 1996; Tachibana et al., 1998;
(IL)-7. Multipotent hematopoietic progenitors are Zou et al., 1998). The studies using mutant mice with
attached to the processes of CXCL12-expressing cells targeted gene disruption have revealed that CXCL12
and pre-pro-B cells adjoin their cell bodies. Maturer and CXCR4 are essential for B cell development and
pro-B cells that require IL-7 have moved away and colonization of bone marrow by hematopoietic stem
adjoin the IL-7-expressing cells. Plasma cells again cells (HSCs) and myeloid lineage cells during ontogeny
seed CXCL12-expressing cells. We demonstrate the as well as blood vessel formation in gastrointestinal
B lymphocyte characteristic location and movement tract, cardiac ventricular septum formation, and cerebel-
between specific niches within bone marrow during lar development (Nagasawa et al., 1996; Tachibana et
development and suggest that CXCL12 maintains the al., 1998; Zou et al., 1998; Egawa et al., 2001; Ara et al.,
cells in the niche. 2003b). Recently, it has been shown that CXCL12 and
CXCR4 are involved in mobilization and homing of pri-
Introduction mordial germ cells (PGCs) into gonads during their de-
velopment in mammals and fish (Doitsidou et al., 2002;
Hematopoiesis occurs within a complex bone marrow Ara et al., 2003a; Knaut et al., 2003). Consistent with
microenvironment. It has been assumed that the bone these, the studies using transfilter migration assay have
marrow contains stromal cells that create the special revealed that various kinds of cells including hematopoi-
etic progenitors migrate in response to CXCL12 in vitromicroenvironments known as niches that maintain blood
(Bleul et al., 1996; Aiuti et al., 1997; Nagasawa et al.,cells and supply the requisite factors for their develop-
1999). In hematopoiesis, it has been reported that thement. However, the lack of distinctive characteristics of
numbers of B lymphoid and myeloid lineage precursors
are decreased in bone marrow but increased in the*Correspondence: tnagasa@frontier.kyoto-u.ac.jp
peripheral blood in chimeric mice reconstituted by4 Present address: Molecular Pathogenesis Program, Skirball Insti-
CXCR4/ fetal liver cells compared with control ani-tute of Biomolecular Medicine, New York University School of Medi-
cine, New York, New York 10016. mals, suggesting that CXCR4 is involved in retaining
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hematopoietic precursors in bone marrow (Ma et al., 2003b). Strong CXCL12/GFP expression was seen in
a small population of stromal cells and the CXCL12-1999). However, the role of CXCL12 and CXCR4 in the
regulation of blood cell behavior within bone marrow expressing cells had several processes, occurred singly
and were uniformly scattered throughout the bone mar-remains unclear.
B cell precursors are among the best characterized row (Figure 1A). Further characterization of the CXCL12-
expressing cells was done on CXCL12/GFP knockinand have contributed an important model system for
hematopoiesis. B lymphocytes are generated from mice using immunohistochemical staining with antibod-
ies to the pan-endothelial marker PECAM-1, the smoothHSCs and develop in bone marrow before they egress
into peripheral blood to reach peripheral lymphoid or- muscle cell marker, smooth muscle -actin (SMA), vas-
cular cell adhesion molecule (VCAM)-1, and the markersgans. Of note, end-stage B cells, plasma cells again
colonize bone marrow. In this study, we examined the for osteoblasts including osteopontin and osteocalcin. It
has been reported previously that expression of CXCL12B lymphocyte behavior within bone marrow during de-
velopment at the cellular and molecular level. We fo- was observed in osteoblasts as well as stromal cells and
endothelial cells in human bone marrow (Ponomaryov etcused our analysis on the stromal cells expressing
CXCL12 and/or interleukin (IL)-7, cytokines that are es- al., 2000). However, almost all of CXCL12-expressing
cells did not express PECAM-1 (data not shown) or thesential for B lymphopoiesis (von Freeden-Jeffry et al.,
1995; Nagasawa et al., 1996; Egawa et al., 2001) and markers for osteoblasts (Figure 1C), indicating that
CXCL12-expressing cells are different from endothelialtheir association with precursors in successive stages
of the B lymphoid lineage using mice in which GFP cells and osteoblasts. Consistent with this, CXCL12-
expressing cells were located some distance from bonegene was knocked into the CXCL12 locus (CXCL12/GFP
knockin mice; Ara et al., 2003a, 2003b). We identified surface and osteoblasts (Figure 1C). Furthermore, al-
most all of CXCL12-expressing cells did not expressstage specific cellular niches for B cell development
including CXCL12-expressing cells and IL-7-expressing SMA (data not shown). In contrast, almost all of
CXCL12-expressing cells expressed VCAM-1 but con-cells and demonstrate that B cell precursors and plasma
cells reside in the specific niches and move between stitute only 17% of VCAM-1 stromal cells (n  600)
(Figure 1D). Considering that VCAM-1 has been shownthe niches as development proceeds. Furthermore, our
results strongly suggest that CXCL12 plays a role in to be expressed in the fibroblast-like cells morphologi-
cally termed reticular cells as well as sinusoid endothe-maintaining the cells in the specific niche.
lial cells within bone marrow (Jacobsen et al., 1996),
CXCL12-expressing cells might be a subset of boneResults
marrow reticular cells.
Next, we analyzed the expression of IL-7 within boneCXCL12-Expressing Cells Are a Small Population
marrow by immunohistochemical staining with an anti-of Stromal Cells, Scattered throughout
body to IL-7. Since both CXCL12 and IL-7 are requiredBone Marrow and Located Some Distance
for B lymphopoiesis, combined expression of CXCL12from IL-7-Expressing Cells
and IL-7 in stromal cells for their synergistic or additiveB cell precursors can be divided into several populations
functions on B cell precursors would be expected (vonby the use of the cell surface markers differentially ex-
Freeden-Jeffry et al., 1995; Nagasawa et al., 1996; Mapressed during development in bone marrow (Hardy and
et al., 1999; Egawa et al., 2001). However, surprisingly,Hayakawa, 1991). B220CD19NK1.1CD43HSAlo/
analysis of bone marrow from CXCL12/GFP knockincells have been shown to progress to B220CD19
mice revealed that IL-7 was not expressed in CXCL12-CD43HSA phenotypes during in vitro stromal cell cul-
expressing cells (Figure 1A). The IL-7-expressing cellsture and suggested to be the earliest identifiable B cell
were scattered throughout bone marrow as has beenprecursors, termed pre-pro-B cells (Hardy and Haya-
previously reported (Funk et al., 1995) and located somekawa, 1991; Li et al., 1996; Rolink et al., 1996; Allman
distance from the CXCL12-expressing cells (Figureet al., 1999). B220CD19CD43HSA cells consist
1A). Immunohistochemical staining revealed that IL-7-mainly of large mitotically active cells, termed pro-B
expressing cells also expressed VCAM-1 (data not shown)cells (Hardy and Hayakawa, 1991; Li et al., 1996). Maturer
and about 46% of VCAM-1 stromal cells (n 121) wereB220CD19CD43 cells consist mainly of small resting
IL-7-expressing cells.cells, termed pre-B cells (Hardy and Hayakawa, 1991).
Early B cell development is known to require cytokines
CXCL12 and IL-7 (von Freeden-Jeffry et al., 1995; Naga- B Cell Precursors Migrate from CXCL12-Expressing
Cells to IL-7-Expressing Cellssawa et al., 1996; Egawa et al., 2001). Previous detailed
analysis using radiation chimeras reconstituted with as Development Proceeds
These results prompted us to examine the associationCXCR4/ or CXCR4/ fetal liver cells have revealed
that CXCL12 is required for pre-pro-B cells (Egawa et between early B cell precursors and CXCL12- or IL-7-
expressing cells. We found, using flow cytometric analy-al., 2001). On the other hand, IL-7 has been shown to
be essential for pro-B cells but not pre-pro-B cells (von sis, that cell surface expression of flk2 was restricted,
within B220 B lymphocytes, to pre-pro-B cells, so thatFreeden-Jeffry et al., 1995). The different cytokine re-
quirement between two early B cell precursor fractions virtually all B220flk2 cells were pre-pro-B cells and
vice versa (Figure 2A; data not shown). On the otherprompted us to examine the localization of cells ex-
pressing CXCL12 or IL-7 (or both) in bone marrow. First, hand, it has been shown previously that expression of
c-kit is restricted, within B lymphocytes, to pro-B cellswe located and analyzed the CXCL12-expressing cells
using CXCL12/GFP knockin mice (Ara et al., 2003a, and B220c-kit cells are the principal pro-B cells (Lo¨f-
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Figure 1. Localization and Characteristics of CXCL12-Expressing Cells within Bone Marrow
(A and B) The distribution of CXCL12-expressing cells and IL-7-expressing cells. The bone marrow sections (10 and 63 magnification)
from CXCL12/GFP knockin mice (A) or sections (10) from control IL-7/ mice (B) were stained with an antibody against IL-7. (A) The CXCL12-
expressing cells (green) are uniformly scattered throughout the marrow and located some distance from IL-7-expressing cells (red). The cells
expressing both CXCL12 and IL-7 (yellow because of the overlap of green and red) are not observed.
(C and D) Characterization of CXCL12-expressing cells. The bone marrow sections from CXCL12/GFP knockin mice were stained with an
antibody against the markers for osteoblasts, osteopontin (red) (C) and VCAM-1 (red) (D). (C) Almost all of CXCL12-expressing cells (green)
are different and located some distance from osteopontin osteoblasts (red). (D) Almost all of CXCL12-expressing cells express VCAM-1
(yellow because of the overlap of green and red) but constitute only a small population of VCAM-1 cells.
fert et al., 1994; Allman et al., 1999; ten Boekel et al., erated B cells that develop from pre-B cells and mature
B cells (Hardy and Hayakawa, 1991; Lo¨ffert et al., 1994)1997). These results allowed detailed observation of a
characteristic localization of pre-pro-B cells and pro-B were not in contact with CXCL12-expressing cells or
IL-7-expressing cells (Table 1).cells. Immunohistochemical analysis with antibodies
against B220, flk2, and c-kit revealed that B220flk2
pre-pro-B cells and B220c-kit pro-B cells occurred Multipotent Hematopoietic Progenitors Are
in Contact with the Processessingly and were uniformly scattered throughout bone
marrow (Figures 2B–2D; data not shown). In CXCL12/ of CXCL12-Expressing Cells
Pre-pro-B cells are generated directly or indirectly fromGFP knockin mice, most of pre-pro-B cells were in con-
tact with the bodies of CXCL12-expressing cells (Figure multipotent hematopoietic progenitors. We therefore
sought to analyze the association between multipotent2B; Table 1). CXCL12-expressing cells had only one pre-
pro-B cells in contact. However, all B220c-kit pro-B hematopoietic progenitors and CXCL12-expressing
cells. It remains difficult to visualize HSCs or commoncells were located at a great distance from CXCL12-
expressing cells (Figure 2C; Table 1). In contrast, immu- lymphoid progenitors (CLPs) that can give rise to T
lymphoid, B lymphoid, and natural killer (NK) cells butnohistochemical analysis revealed that most of pre-
pro-B cells were not in contact with IL-7-expressing not myeloid cells (Kondo et al., 1997; Gounari et al.,
2002; Martin et al., 2003). Previous studies have showncells but almost all B220c-kit pro-B cells adjoined the
IL-7-expressing cells (Figure 2D; Table 1). Subsequently, that Linc-kitSca-1 fraction is highly enriched in vari-
ety of multipotent hematopoietic progenitors includingmost of B220IL-7receptor (R) cells, consisting mainly
of pre-B cells (Lo¨ffert et al., 1994), were not in contact HSCs (Ikuta and Weissman, 1992). Because flow cyto-
metric analysis revealed that the c-kitSca-1 cells werewith CXCL12-expressing cells or IL-7-expressing cells
(Figure 2E; Table 1), suggesting that the cells that differ- Lin (data not shown), immunohistochemical staining
analysis using antibodies against c-kit and Sca-1 wasentiate into pre-B cells leave IL-7-expressing cells. Fur-
thermore, most B220IgM cells comprising newly gen- performed to visualize multipotent hematopoietic pro-
Immunity
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Figure 2. The Interaction of CXCL12-Expressing Cells and IL-7-Expressing Cells with B Cell Precursors during Development
(A) Cell surface expression of flk2 is restricted, within B lymphocytes, to pre-pro-B cells. Gated bone marrow B220CD19NK1.1HSAlo/
(pre-pro-B) or CD19 cells were analyzed for flk2 expression by flow cytometry. CD19 cells contain all B220 B lymphocytes other than pre-
pro-B cells. The results shown are representative of three experiments.
(B and C) The bone marrow sections from CXCL12/GFP knockin mice were stained with antibodies against B220 (blue) and flk2 (red, B) or
c-kit (red, C). (B) The B220flk2 pre-pro-B cell (purple because of the overlap of blue and red) is in contact with the body of the CXCL12-
expressing cell (green). (C) The B220c-kit pro-B cell (purple) is located at a great distance from the CXCL12-expressing cell (green).
(D and E) Wild-type bone marrow sections were stained with antibodies against IL-7 (green), B220 (red) and c-kit (blue, D) or IL-7R (blue, E).
(D) The pro-B cell (purple) adjoins the IL-7-expressing cell (green). (E) The B220IL-7R cell (purple) is not in contact with the IL-7-expressing
cell (green).
genitors (de Bruijn et al., 2002). C-kitSca-1 cells were CXCL12 Induces a Significant Increase in Adhesion
of Pre-Pro-B Cells but Not Pro-B or Pre-B Cellsobserved throughout bone marrow. Interestingly, in the
bone marrow from CXCL12/GFP knockin mice, most of to Stromal Cell-Derived Adhesion Molecules
To address the role of CXCL12 in the selective associa-c-kitSca-1 cells (88 cells out of 105 cells) were in
contact with the course of the processes of CXCL12- tion between pre-pro-B cells and CXCL12-expressing
cells, we compared the effect of CXCL12 on mobilizationexpressing cells (Figure 3) but not with their cell bodies,
raising the possibility that differentiating multipotent he- of pre-pro-B cells and pro-B cells. It has been shown
previously that CXCL12 is a potent attractant for bothmatopoietic progenitors move along the processes of
CXCL12-expressing cells. pre-pro-B and pro-B cells (D’Apuzzo et al., 1997; Bow-
Bone Marrow Cellular Niches for B Lymphopoiesis
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the other B cell precursors with respect to their capacityTable 1. Interactions of B Cell Precursors with Bodies of CXCL12-
Expressing or IL-7-Expressing Cells to adhere to VCAM-1 in vitro.
Contacts with Contacts with
CXCL12 Cells IL-7 Cells Notch-1 Ligands Are Expressed in Some
Bone Marrow Stromal Cells but NotB220flk2 cells 68/105 (65%) 12/107 (11%)
in CXCL12-Expressing CellsB220c-kit cells 0/117 (0.0%) 93/105 (89%)
Notch-1 receptors are transmembrane proteins that areB220IL-7R cells 4/138 (2.9%) 62/201 (31%)
B220IgM cells 4/100 (4.0%) 33/102 (32%) known to deliver key signals for T lymphoid lineage deci-
sion in hematopoietic progenitors, possibly by influenc-We examined individual 105 or 107 B220flk2, 117 or 105 B220
ing lineage commitment from CLPs (Pui et al., 1999;c-kit, 138 or 201 B220IL-7R, and 100 or 102 B220IgM cells in
bone marrow sections (Figures 2B–2E). Most of B220IL-7R cells Radtke et al., 1999). Enforced expression of constitu-
belong to pre-B cells. tively active form of Notch-1 severely decreases the
numbers of cells in all B lineage precursor subsets in-
cluding pre-pro-B and pro-B cells in vivo (Pui et al.,
1999). Real-time quantitative RT-PCR analysis revealedman et al., 2000). Transfilter migration assay revealed
that Notch-1 was highly expressed in pre-pro-B cellsthat pre-pro-B cells and pre-B cells were more respon-
but not in pro-B cells or pre-B cells (data not shown).sive to CXCL12 compared to pro-B cells (Figure 4A; see
These, together with the previous studies that haveSupplemental Figure S1 at http://www.immunity.com/
shown that Notch-1 ligands including Delta-like-1 andcgi/content/full/20/6/707/DC1). On the other hand, it has
Jagged-1 are expressed in bone marrow (Li et al., 1998;been reported that in human bone marrow CXCL12 trig-
Han et al., 2000), prompted us to analyze the expressiongers a sustained adhesion response in B cell precursors
of Notch-1 ligands in bone marrow stromal cells includ-(Glodek et al., 2003). We found that CXCL12 induced a
ing CXCL12-expressing cells. Delta-like-1 and Jagged-1significant increase in adhesion of pre-pro-B cells but
are also transmembrane proteins and Delta-like-1 hasnot pro-B cells or pre-B cells to VCAM-1, which was
been shown to induce the differentiation of multipotentexpressed in both CXCL12-expressing and IL-7-ex-
hematopoietic progenitors into T lymphoid lineage cellspressing cells (Figure 4B). This suggests that CXCL12
while inhibiting the generation of B lymphoid lineageacts selectively on pre-pro-B cells to increase adhesive-
cells in vitro (Jaleco et al., 2001; Schmitt and Zuniga-ness of VCAM-1 ligands including 41 integrin. Flow
Pflucker, 2002). Immunohistochemical analysis of bonecytometric analysis revealed that pre-pro-B, pro-B, and
marrow from CXCL12/GFP knockin mice revealed thatpre-B cells displayed high surface expression of 4 in-
Delta-like-1 and Jagged-1 were detectable in some stro-tegrins (Figure 4C). It therefore appears that the respon-
mal cells including IL-7-expressing cells but undetect-siveness of B cell precursors to CXCL12 may not corre-
able in CXCL12-expressing cells, suggesting thatlate with expression levels of 4 integrins. On the other
Notch-1 in pre-pro-B cells does not deliver a signal sincehand, we observed higher expression of CXCR4 mRNA
pre-pro-B cells are in contact with CXCL12-expressingin pre-pro-B cells and pre-B cells compared to pro-B
cells (data not shown).cells by real-time quantitative RT-PCR analysis (Figure
4D). Flow cytometric analysis revealed that pro-B cells
and pre-B cells displayed higher surface expression of Plasma Cells in Bone Marrow Require CXCL12
and Are in Contact with CXCL12-Expressing CellsCXCR4 (Figure 4E). Thus despite high-level expression
of CXCR4 in pre-pro-B, pro-B, and pre-B cells, pre- B lymphocytes positive for surface immunoglobulin that
develop from pre-B cells in bone marrow egress intopro-B cells were much more responsive to CXCL12 than
Figure 3. C-kitSca-1 Multipotent Hematopoietic Progenitors Are in Contact with the Processes of CXCL12-Expressing Cells
The bone marrow sections from CXCL12/GFP knockin mice were stained with antibodies against c-kit (red) and Sca-1 (blue). Two c-kitSca-
1 cells (purple because of the overlap of blue and red) contacting the course of the processes of CXCL12-expressing cells (green) are shown.
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Figure 4. Pre-Pro-B Cells but not Pro-B or
Pre-B Cells Exhibited Adhesive Activities to
VCAM-1 in Response to CXCL12
(A) Pre-pro-B and pre-B cells were more re-
sponsive to CXCL12 compared to pro-B cells
with respect to their capacity for chemotaxis.
Shown are the frequencies of migrating cells
(the mean and SD of data derived from
three experiments).
(B) CXCL12 induced a significant increase in
adhesion of pre-pro-B cells but not pro-B
cells or pre-B cells to VCAM-1. The frequen-
cies of adherent cells are shown. Shown are
the frequencies of adherent cells (the mean
and SD of data derived from six experiments).
*, p  0.01 by Student’s t test.
(C) Flow cytometric analysis of 4 integrins
surface expression in pre-pro-B (dotted), pro-
B (plain) and pre-B cells (bold) along with the
isotype control (tinted). The results shown are
representative of three experiments.
(D) Higher expression of CXCR4 in pre-pro-
B cells and pre-B cells compared to pro-B
cells. The CXCR4 mRNA levels were quanti-
tated by real-time quantitative RT-PCR. The
mean and SD of data derived from three ex-
periments is shown.
(E) Flow cytometric analysis of CXCR4 sur-
face expression in pre-pro-B (dotted), pro-B
(plain) and pre-B cells (bold) along with the
isotype control (tinted). The results shown are
representative of six experiments.
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peripheral blood to reach the spleen and mature to pe- CXCL12-expressing cells and migrate through the mes-
enchyme to reach IL-7-expressing cells since most ofripheral mature B cells. Plasma cells are end-stage B
pro-B cells adjoin IL-7-expressing cells (Figure 6). Con-cells that develop following antigen activation of mature
sidering that pro-B cells are mitotically active (HardyB cells and are critical for mediating the humoral immune
and Hayakawa, 1991) and require IL-7 in their prolifera-response because they alone synthesize and secrete
tion (von Freeden-Jeffry et al., 1995), the IL-7-expressinglarge amounts of antigen-specific antibodies. Long-term
cells are likely to provide the niches that induce anantibody production by long-term plasma cells is one
expansion division. In this case, the precursors wouldof the hallmarks of effective vaccination and is an impor-
move from the niche for cell fate decision to the nichetant characteristic of immunological memory. Of note,
for cell proliferation during B lymphopoiesis. Since onethe majority of long-lived plasma cells reside in the bone
CXCL12-expressing cell or IL-7-expressing cell main-marrow. The previous study using chimeric mice recon-
tained only one pre-pro-B cell or pro-B cell (Figures 2Bstituted with CXCR4/ fetal liver cells has shown that
and 2D), there might be a strict regulation in space ofCXCR4/ plasma cells fail to home to the bone marrow
the functions of the cellular niches in B lymphopoiesis.(Hargreaves et al., 2001). Since the chimeric mice recon-
Our results have revealed that most of the cells thatstituted with CXCR4/ fetal liver cells display deficits
differentiate into pre-B cells were not in contact within early B lymphopoiesis, we analyzed the role of CXCR4
CXCL12-expressing or IL-7-expressing cells. This isin plasma cells using conditional CXCR4-deficient mice
consistent with the idea that pre-B cells become inde-in which CXCR4 was specifically deleted from mature
pendent on stromal microenvironment (Hardy and Haya-B cells. We generated the mice with a loxP-CXCR4 con-
kawa, 1991; Rolink et al., 2000). Why do pre-pro-B cellsditional targeting allele (CXCR4flox/ mice) (Figure 5A) and
reside in the specific niches that are different from thecrossed them to mice that express Cre-recombinase
niches maintaining pro-B cells? It is likely that appro-under the control of the endogenous B cell-specific
priate combinations of microenvironmental factors thatCD19 locus (Rickert et al., 1997). Deletion by CD19-Cre
support the development of pre-pro-B and pro-B cellsongoing throughout B lymphopoiesis resulted in a lower
are different. It has been shown that stimulation withdeletion efficiency in pre-B cells compared to mature B
thymic environment or several cytokines induces the Bcells in the spleen as previously described (Rickert et
cell precursors in the mice lacking a transcription factoral., 1997; Figure 5C; data not shown). In CXCR4flox//
Pax-5 to differentiate into T lymphoid, NK, or myeloidCD19-Cre mice, the numbers of mature B cells and
lineages, indicating that Pax-5 induces irreversible Bplasma cells in spleen were normal (Figure 5D; data not
lymphoid lineage commitment (Nutt et al., 1999; Rolinkshown) but the numbers of plasma cells in bone marrow
et al., 1999). Considering that Pax-5 is barely detectablewere severely reduced compared with CXCR4flox//
in pre-pro-B cells and expressed from pro-B cells byCD19-Cre mice supporting the idea that bone marrow
real-time quantitative RT-PCR (data not shown), the pre-plasma cells require CXCR4 (Figure 5E). These results
pro-B cells would be still responsive to lineage-inap-prompted us to determine the association of plasma
propriate signals. These raise the possibility that pre-cells with CXCL12-expressing cells within bone marrow.
pro-B cells are protected against lineage-inappropriateImmunohistological analysis using antibodies against
signals in the specific niches. Consistent with the hy-IgG and the plasma cell marker, Syndecan-1 (Sanderson
pothesis, the ligands for Notch-1 that have been shownet al., 1989; Lalor et al., 1992), was performed to visualize
to induce T lymphoid lineage commitment (Pui et al.,plasma cells. The IgGSyndecan-1 cells sorted from
1999; Radtke et al., 1999; Jaleco et al., 2001; Schmittwild-type bone marrow and stained with May-Gru¨nwald-
and Zuniga-Pflucker, 2002) are expressed in some stro-Giemsa had the typical morphology of plasma cells, with
mal cells but not in CXCL12-expressing cells within boneenlarged cytoplasm and an eccentric nucleus (Figure
marrow. Whether CXCL12-expressing cell niches are5F). The numbers of IgGSyndecan-1 plasma cells in
specific for B lymphoid lineage and whether in other
the bone marrow sections of CXCR4flox//CD19-Cre mice
hematopoietic lineages a similar scenario occurs, in
were severely reduced compared to CXCR4flox//CD19-
which the earliest precursors reside in the specific niche
Cre mice (Figure 5G). Analysis of bone marrow from distinct from the niche for their extensive proliferation
CXCL12/GFP knockin mice revealed that almost all of are important questions for the future. Identification and
IgGSyndecan-1 plasma cells were in contact with the visualization of early precursors for other hematopoietic
processes or bodies of CXCL12-expressing cells (93 lineages will be needed to address these issues.
cells out of 100 cells) (Figure 5H). Pre-pro-B cells are thought to generate from multipo-
tent hematopoietic progenitors including CLPs and
Discussion HSCs. The localization of CLPs or HSCs remains elusive
due to the difficulty of visualizing these progenitors.
In the present report, we assessed the cellular niches However, our finding that most cells in c-kitSca-1
for B lymphopoiesis and the systemic movement of B multipotent hematopoietic progenitor fraction adhere to
lymphocytes within bone marrow during development. the processes of CXCL12-expressing cells raises the
Since most of pre-pro-B cells were in contact with possibility that cells during or immediately after commit-
CXCL12-expressing cells, a small population of stromal ment to B lymphoid lineage move centrally to the bodies
cells, CXCL12-expressing cells would constitute a spe- of CXCL12-expressing cells along the processes of
cific niche for precursors at the earliest stages of B CXCL12-expressing cells (Figure 6). On the other hand,
lymphopoiesis. This raises the possibility that the niche considering our previous findings that CXCL12-express-
supports B lymphoid lineage commitment and/or sur- ing cells might act as a hematopoietic stem cell niche
in fetal bone marrow (Ara et al., 2003b), there is alsovival of the precursors. The precursors then would leave
Immunity
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Figure 5. Plasma Cells in Bone Marrow Require CXCL12 and Are in Contact with CXCL12-Expressing Cells
(A) Generation of the floxed CXCR4 locus. Restriction endonuclease map of the wild-type CXCR4 locus, the targeting vector, the initial targeted
locus, floxed locus after neo deletion and targeted locus after complete deletion.
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were in contact with CXCL12-expressing cells in vivo
raise the possibility that the precursors require CXCL12-
induced increase in adhesiveness of VCAM-1 ligands
but not migration to CXCL12 for residing in CXCL12-
expressing cell niche. In this case, CXCL12 would con-
trol the anchorage of pre-pro-B cells in the niche. 4
integrin, a subunit of VCAM-1 ligands, is a candidate for
targets for the CXCL12 function because 4 integrin has
been shown to be essential for early B lymphopoiesis
in bone marrow (Arroyo et al., 1996). There is also the
possibility that CXCL12 acts directly to promote survi-
val or differentiation of the precursors. Furthermore,
CXCL12 might attract the progenitors along the pro-
cesses of the CXCL12-expressing cells. On the other
hand, as development proceeds, the cells lose the con-
tact with CXCL12-expressing cells (Figure 6). Of note,
pro-B cells and pre-B cells that are located at a great
distance from CXCL12-expressing cells express high
level of CXCR4 but do not display CXCL12-mediated
upregulation of adhesion to VCAM-1 (Figure 4). The un-
derlying mechanisms are not well understood, but cells
would become less responsive to CXCL12 with respect
to their capacity to adhere to CXCL12-expressing cellsFigure 6. Model of the Movement of Multipotent Hematopoietic
Progenitors and B Lymphocytes, and Their Association with Specific due to alterations in intracellular signaling pathways
Cellular Niches within Bone Marrow during Development stimulated by CXCR4. Additionally, IL-7-expressing cells
are likely to secrete another attractant(s) for pro-B cells.
We have shown that plasma cells in bone marrowthe possibility that HSCs remain adjacent to CXCL12-
require CXCL12 and are in contact with CXCL12-expressing cells in adult bone marrow. Recent studies
expressing cells. Together with the previous studiessuggest that HSCs are located near the osteoblastic
(Hargreaves et al., 2001; Cassese et al., 2003), thesecells lining the bone surface (Calvi et al., 2003; Zhang
suggest that CXCL12 supports homing and survival ofet al., 2003). In this case, intermediates between HSCs
plasma cells in the niches in bone marrow. It is intriguingand pre-pro-B cells (Tudor et al., 2000) would move from
that the earliest B cell precursors and end-stage B cellsthe bone surface toward the CXCL12-expressing cells
share the common cellular niche. This may be a reasonthat are located some distance from osteoblasts and
for the result that patients with multiple myeloma, a Bdispersed throughout bone marrow. Recently, it has
cell malignancy characterized by excess plasma cellsbeen shown that a small population of pre-pro-B cells
in the bone marrow show severely reduced numbers ofhave the capacity to colonize the thymus and differenti-
B lymphocytes (Pilarski et al., 1984).ate into all lymphoid lineages (Martin et al., 2003). Further
T cell precursors migrate from region of the perimedul-studies will be needed to see if the cells in this population
lary cortex to the subcapsular region through the cortexare in contact with CXCL12-expressing cells.
in thymus as development proceeds (Norment andSince donor-derived pre-pro-B cells were almost ab-
Bevan, 2000; Lind et al., 2001). In contrast, we havesent in the bone marrow from chimeric mice long-term
shown that the early B cell precursors and plasma cellsreconstituted with CXCR4/ fetal liver cells as com-
reside in the specific cellular niches which were uni-pared with control chimeras (Egawa et al., 2001),
formly scattered throughout bone marrow and moveCXCL12 is likely to play a role in maintaining the precur-
between the niches during development in vivo. Thissors in their specific niche. The results that CXCL12
study provides a novel basis for probing the mecha-induced the migration of pre-pro-B, pro-B, and pre-B
nisms by which physical microenvironments support he-cells but increased adhesiveness of VCAM-1 ligands
only on pre-pro-B cells in vitro and only pre-pro-B cells matopoiesis within bone marrow.
(B) PCR genotyping analysis of adult wild-type and CXCR4flox//CD19-Cre mice.
(C) Flow cytometric analysis of CXCR4 surface expression in mature B cells in the spleen of CXCR4flox//CD19-Cre (plain) and CXCR4flox//
CD19-Cre (bold) mice along with the isotype control (dotted). The results shown are representative of eight experiments.
(D) The numbers of mature B cells in the spleen of CXCR4flox//CD19-Cre and CXCR4flox//CD19-Cre mice were determined by flow cytometric
analysis. n  4.
(E) The numbers of IgG plasma cells in the bone marrow of CXCR4flox//CD19-Cre and CXCR4flox//CD19-Cre mice were determined by ELISPOT.
n  3.
(F) Cytospin preparations of FACS-sorted IgGSyndecan-1 cells were stained with May-Gru¨nwald-Giemsa.
(G) The numbers of IgGSyndecan-1 cells in bone marrow sections of CXCR4flox//CD19-Cre and CXCR4flox//CD19-Cre mice were quantified.
The data presented are the average of 12 sections.
(H) The bone marrow sections from CXCL12/GFP knockin mice were stained with antibodies against IgG (blue) and Syndecan-1 (red). The
IgGSyndecan-1 plasma cell (purple because of the overlap of blue and red) is in contact with the process and body of the CXCL12-
expressing cell (green).
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Experimental Procedures dardized washing procedure (four cycles) in an automated plate
washer (Bio-Tek) using HBSS (10 mM Hepes, 1 mM Mg2, and 1 mM
Ca2 [pH 7.4]). Adherent cells were collected, stained, and analyzedMice
The generation of CXCL12/GFP knockin mice has been described by flow cytometry. Adhesion was calculated as a percentage of
input samples. Mouse VCAM-1/Fc and human IgG1 were purchasedpreviously (Ara et al., 2003a, 2003b). CXCL12/GFP knockin and
CXCR4flox/ mice were backcrossed more than seven times with from R&D Systems and Sigma, respectively.
C57BL/6-Ly5.2 mice. IL-7/ mice were a gift from Dr. H. Kiyono.
CXCR4flox/ mice were generated according to the standard two- ELISPOT Assay
step procedure. The CXCR4 locus was modified by conditional gene Plates were coated with anti-IgG (1 g/ml in 0.05 M carbonate buffer
targeting in E14.1 embryonic stem (ES) cells derived from 129 mice [pH 9.6]; Southern Biotechnology) and blocked with 1% BSA in PBS.
(Nagasawa et al., 1996). The targeting construct introduced a floxed Fresh bone marrow cells were then added in RPMI/5% FCS and
neomycin resistance cassette in the intron preceding the exon 2 incubated 5 hr at 37	C. The plates were then incubated with alkaline
and a loxP site downstream of the exon 2. The neomycin cassette phosphatase-conjugated anti-IgG (Southern Biotechnology) fol-
was removed subsequently from targeted ES cell clones by transient lowed by the substrate 5-bromo-4-chloro-3-indolylphosphate
expression of Cre, yielding the final floxed allele. For conditional (Sigma) until spots were clearly visible.
inactivation, we have crossed them to mice that express Cre-recom-
binase under the control of the endogenous B cell-specific CD19
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